Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

GZD856 MeSH Supplementary Concept Data 2025


MeSH Supplementary
GZD856
Unique ID
C000609603
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000609603
Entry Term(s)
4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl) -3-(trifluoromethyl)phenyl)-3-(parasol(1,5-a)pyrimidin-6-ylethynyl)benzamide
Registry Numbers
0
Heading Mapped to
*Benzamides
Frequency
2
Note
antineoplastic; potent inhibitor of PDGFRalpha/beta; structure in first source
Source
Cancer Lett. 2016 May 28;375(1):172-8
Date of Entry
2016/08/05
Revision Date
2016/08/05
GZD856 Preferred
4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl) -3-(trifluoromethyl)phenyl)-3-(parasol(1,5-a)pyrimidin-6-ylethynyl)benzamide Broader
page delivered in 0.001s